BioVie Inc —— 资产负债表 (NASDAQ:BIVI) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 6.05 M20.11 M35.1 M25.21 M21.56 M 负债总额 996.37 K16.44 M19.76 M9.7 M2.55 M 权益总额 5.05 M3.67 M15.34 M15.51 M19.01 M 负债及股东权益总额 6.05 M20.11 M35.1 M25.21 M21.56 M 总债务 012.14 M14.33 M5.7 M1.2 M 净债务 -4.51 M-6.5 M-5.13 M-18.14 M-16.34 M

新闻

BioVie分拆的肝病药企Option Therapeutics(OPTN.US)缩减IPO规模下调募资额20%至2000万美元

BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID Transcript

BioVie拆分肝病业务 Option Therapeutics(OPTN.US)启动美股IPO

BioVie completes enrollment for Parkinson’s drug trial

What Makes BioVie (BIVI) a New Buy Stock

BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease Transcript

BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease - Slideshow (NASDAQ:BIVI) 2025-12-09

BioVie股东在年度会议上批准修订股权激励计划

BioVie shareholders approve amendment to equity incentive plan at annual meeting

BioVie股东在年度会议上批准董事会提名人选和股权计划

BioVie shareholders approve board nominees and equity plan at annual meeting

Akari Therapeutics任命Kameel Farag为临时首席财务官